Search Within

Andrew D Seidman

  1. "Elsevier Inc."
Formats
  1. Journal Article (40)
  2. Meeting Abstract (9)
  3. Conference Paper (4)
  4. Research Letter (1)
  5. Review (1)
Groups
  1. Breast Medicine Service (55)
  2. Department of Medicine (55)
  3. Solid Tumor Oncology Division (55)
  4. Survivorship Research (29)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (21)
  6. Epidemiology and Biostatistics (14)

More Groups

People
  1. Clifford Hudis (17)
  2. Larry Norton (14)
  3. Jonathan Yang (7)
  4. Shanu Modi (7)
  5. Zhigang Zhang (7)
  6. Gabriella D'Andrea-Carlino (6)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (1)
  4. 2022 (2)
  5. 2021 (2)
  6. 2018 (4)

More Years

Publications
  1. Clinical Breast Cancer (19)
  2. Seminars in Oncology (16)
  3. International Journal of Radiation Oncology, Biology, Physics (8)
  4. European Journal of Cancer (4)
  5. Breast (2)
  6. Breast Diseases: A Year Book Quarterly (2)

More Publications

Publishers
  1. Elsevier Inc. (55)

Results (55)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dose dense cyclophosphamide, methotrexate, fluorouracil is feasible at 14-day intervals: a pilot study of every-14-day dosing as adjuvant therapy for breast cancer
    Journal Article

    Drullinsky, P.; Sugarman, S. M.; Fornier, M. N.; D'Andrea, G.; Gilewski, T.; Lake, D.; Traina, T.; Wasserheit-Lieblich, C.; Sklarin, N.; Atieh-Graham, D.; more...
    Clinical Breast Cancer (2010)

    Fulltext@MSK | Save
  • Phase II trial of weekly nanoparticle albumin-bound paclitaxel with carboplatin and trastuzumab as first-line therapy for women with HER2-overexpressing metastatic breast cancer
    Journal Article

    Conlin, A.; Seidman, A.; Bach, A.; Lake, D.; Dickler, M.; D'Andrea, G.; Traina, T.; Danso, M.; Brufsky, A.; Saleh, M.; more...
    Clinical Breast Cancer (2010)

    Fulltext@MSK | Save
  • Evolving approaches to metastatic breast cancer previously treated with anthracyclines and taxanes
    Journal Article

    Murphy, C. G.; Seidman, A. D.
    Clinical Breast Cancer (2009)

    Fulltext@MSK | Save
  • Treatment strategies for patients with anthracycline- and taxane-pretreated metastatic breast cancer
    Journal Article

    Seidman, A. D.
    Seminars in Oncology (2008)

    Fulltext@MSK | Save
  • Beyond cytotoxic chemotherapy for the first-line treatment of HER2-negative, hormone-insensitive metastatic breast cancer: Current status and future opportunities
    Journal Article

    Conlin, A. K.; Seidman, A. D.
    Clinical Breast Cancer (2008)

    Fulltext@MSK | Save
  • Current and emerging systemic treatment strategies for breast cancer - Preface
    Journal Article

    Seidman, A. D.
    Hematology/Oncology Clinics of North America (2007)

    Fulltext@MSK | Save
  • Emerging targeted therapies for breast cancer
    Journal Article

    Arnedos, M.; Seidman, A. D.
    Hematology/Oncology Clinics of North America (2007)

    Fulltext@MSK | Save
  • Adjuvant therapy with aromatase inhibitors for postmenopausal women with early breast cancer: Evidence and ongoing controversy
    Journal Article

    Wheler, J.; Johnson, M.; Seidman, A.
    Seminars in Oncology (2006)

    Fulltext@MSK | Save
  • A phase I study of cetuximab in combination with paclitaxel in patients with advanced-stage breast cancer
    Journal Article

    Modi, S.; D'Andrea, G.; Norton, L.; Yao, T. J.; Caravelli, J.; Rosen, P. P.; Hudis, C.; Seidman, A. D.
    Clinical Breast Cancer (2006)

    Fulltext@MSK | Save
  • Pilot trial of trastuzumab starting with or after the doxorubicin component of a doxorubicin plus paclitaxel regimen for women with HER2-positive advanced breast cancer
    Journal Article

    Seidman, A. D.
    Breast Diseases: A Year Book Quarterly (2005)

    Fulltext@MSK | Save